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ORIGINAL ARTICLE
An Intraocular Inﬂammatory Proﬁle of Rubella
Associated Uveitis
Z. Fazil1, J.C. Ten Berge1, A.W. Langerak2, A. Rothova*1, and W.A. Dik*2
1Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands and
2Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center,
Rotterdam, The Netherlands
ABSTRACT
Purpose: To analyze intraocular cytokine levels and cell proﬁles in patients with rubella virus-associated
uveitis (RVU).
Methods: We collected intraocular ﬂuid samples from patients with RVU (n = 10), uveitis of other causes (n = 27),
and cataract (n = 22). Levels of 15 cytokines (IL-1β, IL-1ra, IL-2, IL-6, IL-6rα, IL-7, IL-8, IL-10, IL-17A, IL-23,
TARC, MCP-1, TNF-α, PlGF, and VEGF) were measured using multiplex assay, and intraocular cell populations
were determined by multiparameter ﬂowcytometry. Clinical characteristics of RVU patients were collected and
compared to laboratory outcomes.
Results: RVU patients exhibited high intraocular levels of MCP-1, IL-6rα, and TARC, whilst patients with
noninfectious uveitis were characterized by high levels of PlGF. Cataract patients showed high levels of IL-2
and IL-23. Intraocular cell population of RVU patients disclosed mainly T-cells and monocytes/macrophages and
B-cells were scarcely detected.
Conclusion: RVU patients exhibit a cytokine proﬁle distinct from noninfectious uveitis and cataract.
Keywords: Cytokines, Fuchs uveitis syndrome, immunopathology, rubella-virus associated uveitis, intraocular ﬂuid
Rubella virus-associated uveitis (RVU) was ﬁrst
reported by Quentin and Reiber as a major cause of
Fuchs uveitis syndrome (FUS).1,2 Multiple subsequent
studies conﬁrmed this association.3–5 However, other
causes of FUS were also repeatedly reported, and
CMV has been identiﬁed as a potential cause of FUS
in Asia.6 Previous studies on cytokine proﬁles and
intraocular inﬂammatory cells were predominantly
performed in patients with clinical characteristics of
FUS or in general uveitis cohorts. Studies of RVU
patients addressing intraocular cytokine proﬁles and
immune cell inﬁltration are mostly lacking.7–15
Herein, we investigate speciﬁc cytokine-, chemo-
kine-, and growth factor levels in intraocular ﬂuid
samples from patients with RVU and compare these
to noninfectious uveitis and cataract. In addition, we
study the intraocular cell population of two RVU
patients.
METHODS
Sample Collection
Remainders of intraocular ﬂuid samples from a total of
59 patients, including RVU (n = 10), noninfectious
uveitis (n = 27), and cataract (n = 22) were obtained
from the biobank at the Erasmus University Medical
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Center, Rotterdam, the Netherlands. All intraocular
ﬂuid samples were stored at −80°C.The study was
approved by the local ethical committee and adhered
to the tenets of the Declaration of Helsinki. All subjects
gave consent and signed a biobank Informed Consent.
Patients and Data Collection
The diagnosis of RVU was based on positive anterior
chamber ﬂuid analysis for rubella virus using poly-
merase chain reaction (PCR) and/or Goldmann-
Witmer Coefﬁcient (GWC). The uveitis group con-
sisted of patients with different types of noninfectious
uveitis: birdshot retinopathy (n = 4), HLA-B27 acute
anterior uveitis (n = 6), multiple sclerosis-associated
uveitis (n = 5), sarcoidosis-associated uveitis (n = 10),
and lastly patients with rubella-virus negative FUS
(n = 2). Patients with age-related cataract had no
other ocular co-morbidities. Basic characteristics
including age, gender and disease duration were gath-
ered for all patients. Clinical ocular characteristics
were collected of all RVU patients and uveitis controls
using electronic patient ﬁles. These characteristics
included location of uveitis, activity of uveitis, pre-
sence of vitritis and various complications such as
cataract, presence of cystoid macular edema (CME),
posterior synechiae and glaucoma, and the use of sys-
temic immunosuppressive medications, systemic corti-
costeroids, as well as local steroid treatments.
Laboratory Analyses
Measurement of interleukins (IL-1β, IL-1ra, IL-2, IL-6, IL-
6rα, IL-7, IL-8, IL-10, IL-17A, IL-23), thymus- and activa-
tion-regulated chemokine (TARC), monocyte chemoat-
tractant protein-1 (MCP-1), tumor necrosis factor-alpha
(TNF-α), placental growth factor (PlGF), and vascular
endothelial growth factor (VEGF) was performed in all
patients, with the exception of one patient with RVU.
Selection of the cytokine panel was based on potential
relevance according to previous reports and/or possible
targets for treatment options. Analysis was performed
using a Luminex multiplex bead immunoassay system
(R&D Systems Europe, Ltd; UK) according to the manu-
facturer’s instructions with exception of one additional
dilution step for the standard curve. Brieﬂy, 50 µL of
undiluted intraocular ﬂuid samples were transferred to
the plate, with exception of intraocular ﬂuid samples
with insufﬁcient amount of material (n = 13), which
were diluted to a total volume of 50 µL. Measurements
were performed on a Bio-Plex MAGPIX instrument and
datawas analyzed using Bio-PlexManagerMP software.
Cellular composition using ﬂowcytometric immunophe-
notypingwas performed in intraocular ﬂuid of two RVU
patients, as described previously.16
Statistical Analysis
Data from the Luminex immunoassay were analyzed
both as continuous and categorical data. For continu-
ous analyses, values below the lower limit of detection
were replaced by the lowest value of the reference
curve. For categorical analyses, the lower limit of
detection was used for every individual cytokine as a
cut-off for those cases not showing expression. The
lowest value of the reference curve served as cut-off
point. Continuous variables were presented using
medians, and categorical variables were presented
using percentages. Logistic and linear regressions
with age, gender and diagnosis in the model were
performed to compare laboratory outcomes between
diagnosis groups. A p-value of <0.05 was considered
as statistically signiﬁcant. Statistical analyses were per-
formed using IBM SPSS Statistics, version 21.
RESULTS
Patient Characteristics
The three separate groups showed similar gender dis-
tribution, but differed in age (p < 0.001); speciﬁcally,
RVU patients were younger and patients with cataract
were older (Table 1).
Prevalence of Intraocular Cytokines
Some cytokines were prevalent in all samples (IL-2, IL-
6rα, and MCP-1), while other cytokines were never
detected (IL-1 β and IL-17A). Presence or absence of
cytokine, chemokine or growth factor showed no asso-
ciation with any of the three included groups.
TABLE 1. Patient characteristics.
Rubella virus uveitis Uveitis of other origin Cataract p-value
Total number N = 10 N = 27 N = 22
Age in years (median, range) 40 (27–71) 53 (25–79) 66 (18–80) <0.001
Gender (males) N = 5 (50%) N = 9 (33%) N = 8 (36%) n.s.
Disease duration in years (median, range) 4 (1–35) 4 (1–33) 1 (0–5)
Abbreviation: n.s. = not signiﬁcant.
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Levels of Intraocular Cytokines
The measured levels of intraocular cytokines showed no
association with gender, however levels of IL-6, IL-7 and
IL-23 increasedwith age (p=0.012, p=0.039, and p=0.015,
respectively). The intraocular levels of cytokines show
distinct proﬁles for different groups (Table 2, Figure 1).
RVU cases displayed higher MCP-1, IL-6rα and IL-23
levels than the uveitis control population, whereas the
level of PlGF was lower. Moreover, RVU patients exhib-
ited higher levels of IL-6, IL-6rα, MCP-1, and TARC than
intraocular ﬂuid samples of cataract patients, whilst IL-23
and PlGF were lower. Interestingly, IL-23 levels were
much higher in samples of cataract patients compared to
samples of patients with RVU and uveitis of other origin.
The cytokine proﬁles of RVU patients differed from the
proﬁle of two patients with RV-negative FUS; in RVU
levels of MCP-1, IL-23, and IL-2 were higher and levels
of IL-7 were lower (signiﬁcances were not determined
because of the small sample size).
Associations between Clinical Features and
Cytokines Levels
We assessed associations between multiple clinical fea-
tures and cytokine levels for all our uveitis patients
(N = 36; 9 RVU patients and 27 noninfectious uveitis
controls; Table 3).
Secondary glaucoma was noted in 4/9 (44%) of
RVU patients and in 13/36 (36%) of all uveitis
patients, and was associated with higher levels of
MCP-1. The use of systemic immunosuppressive med-
ications as well as the use of corticosteroid drops were
not associated with any changes of intraocular cyto-
kines levels. Relationships between the clinical features
and the levels of cytokines within the group of 10 RVU
patients were not found.
Intraocular Cell Population in RVU Patients
Flow cytometric analysis of two intraocular RVU sam-
ples disclosed an inﬁltration of mainly T-cells andmono-
cytes/macrophages, whereas B-cells were hardly
detected. Within the T-cell fraction, in one case a clear
dominance of CD8 + T-cells was seen, whereas in the
other case, both CD4+ and CD8 + T-cells were identiﬁed.
DISCUSSION
Our study shows that RVU patients have an intraocu-
lar cytokine proﬁle distinct from patients with uveitis
of non-RVU origin and cataract controls; speciﬁcally,
MCP1, IL-6rα and IL-23 levels were higher, and PlGF
lower than in uveitis controls.
Inﬂammatory ocular diseases are predominantly
characterized by high intraocular IL-6 levels, which
were also observed in this study.17–19 The high levels
of MCP-1 and IL-6 in RVU are consistent with the
results measured in other infectious uveitis.7,20–22 One
recent study included RVU patients as controls while
studying intraocular proﬁle of cytokines in patients
with acute retinal necrosis.15 This study disclosed cyto-
kine results similar to us (elevated MCP-1 and IL-6).
Intraocular IL-6rα, IL-23, and PlGF in RVU have not
yet been investigated in other infectious uveitis, and
TABLE 2. Levels of intraocular cytokines/chemokines/growth factors in patients with rubella virus associated uveitis, uveitis of other
origin and cataract.
Cytokines
RVU
(N = 9)
Median (range)
Uveitis of other origin (N = 27)
Median (range)
Cataract
(N = 22)
Median (range)
p-value
RVU vs cataract
p-value
RVU vs uveitis
Cytokines IL-1β N.A.* 5 (5–7)† N.A.* n.s. n.s.
IL-1ra 405 (187–1633) 148 (9–2279)† 124 (9–2357)† n.s. n.s.
IL-2 232 (131–623) 235 (92–539) 275 (212–1101) n.s. n.s.
IL-6rα 387 (122–3517) 228 (23–567)† 87 (25–264) <0.001 0.003
IL-6 20 (5–522) 10 (2–350)† 2 (2–152)† 0.002 n.s.
IL-7 N.A.* 3 (1–18)† 2 (1–9)† n.s. n.s.
IL-10 4 (4–37)† N.A.* 4 (4–8)† n.s. n.s.
IL-17A N.A.* N.A.* N.A.* n.s. n.s.
IL-23 279 (78–454)† 136 (26–367)† 2592 (144–3494) 0.011 0.028
TNF-α N.A.* 3 (3–10)† 3 (3–3)† n.s. n.s.
Chemokines IL-8 47 (8–912) 18 (1–334)† 6 (1–17)† n.s. n.s.
TARC 34 (29–41)† 29 (29–154)† N.A.* 0.002 n.s.
MCP-1 1472 (267–4526) 581 (14–4225) 618 (250–1920) 0.006 0.029
Growth factors PlGF 1 (1–4)† 6 (1–14) 5 (3–13) <0.001 0.008
VEGF 10 (3–68)† 57 (3–326)† 64 (7–102) n.s. n.s.
Abbreviation: RVU = rubella associated uveitis; n.s. = not signiﬁcant, n.a. = not applicable.
* All values were measured below the detection limit.
† Includes values measured below the detection limit.
Intraocular Inﬂammatory Proﬁle of RVU 3
Published with license by Taylor & Francis.
their possible distinctive character could therefore not
be established. Interestingly, IL-6rα can induce IL-6
trans-signaling by the IL-6/sIL-6Rα complex, which
subsequently could enhance IL-6 activity.23
The higher levels of IL-6 in RVU cases compared to
noninﬂammatory controls is similar to previous data
on intraocular cytokines in FUS (without information
on RV presence or absence).14 However, when com-
paring levels of intraocular IL-6 in RVU with inﬂam-
matory uveitis controls, our study shows more
elevated levels in RVU (not signiﬁcant), whereas
previously they were measured lower in FUS.17 This
difference might be due to rubella-virus status, com-
position of the control uveitis group and/or higher
activity of inﬂammation in our RVU patients. It is
feasible that the FUS samples in previous studies
were obtained predominantly during the cataract
extraction while on anti-inﬂammatory treatment
whilst our samples were mainly obtained during the
active period of inﬂammation for diagnostic purposes.
The included rubella virus-negative FUS cases in our
study had a cytokine proﬁle which was not consistent
with RVU samples, supporting that there is a distinc-
tion between rubella virus-negative FUS and RVU in
pathophysiology.3,4
RVU was associated with high intraocular MCP-1.
MCP-1 is a main chemotactic cytokine to control
migration and inﬁltration of monocytes/macrophages
during inﬂammation which also contributes to anti-
viral responses.24 In line with this ﬁnding, we
observed clear monocyte inﬁltration in two of the
RVU cases examined. The high MCP-1 levels in RVU
may thus reﬂect the viral nature of this disease.
Responses of monocytes/macrophages to viral (and
other) infections are controlled largely by activation
of speciﬁc toll-like receptors (TLR) inducing produc-
tion of pro-inﬂammatory mediators involved in activa-
tion of both innate and adaptive immune responses.
Remarkably, RVU had lower PlGF than other types of
uveitis. PlGF was recently found to enhance the
inﬂammatory response of monocytes upon TLR7/8
activation, TLRs typically activated by single stranded
RNA viruses.25 The low PlGF in RVU may represent a
mechanism to hamper excessive inﬂammation to con-
trol ocular damage, which is in agreement with the
immune privileged site of the eye.
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FIGURE 1. Levels of cytokines in rubella virus associated uveitis, uveitis of other origin and cataract.
p-values were determined by linear regression with adjustment for age and gender.
TABLE 3. Associations between clinical features of uveitis
patients and cytokine levels.
Clinical features
Signiﬁcant cytokine
level changes*
Location
– Anterior High VEGF (p=0.001)
– Intermediate None
– Posterior None
– Panuveitis None
Activity of uveitis None
Vitritis Low VEGF (p=0.002)
Complications
– Posterior synechiae None
– Cataract None
– Cystoid macular edema None
– Secondary glaucoma High MCP-1 (p=0.003)
Treatment
– Systemic immunosuppressive None
– Local corticosteroid drops None
*All results were corrected for multiple testing by Bonferroni
correction, and therefore only p-values ≤0.003 were considered
signiﬁcant. p-values were determined by linear regression with
adjustment for age and gender.
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Our study includes measurements of intraocular
ﬂuids without simultaneous analyses of cytokines
in serum. However, such studies were previously
performed and revealed that sera of patients with
uveitis roughly did not differ from controls (with
the exception of patients with systemic inﬂamma-
tory involvement).15,26,27 Comparison of intraocular
and serum levels might indicate which cytokines
are produced within the eye and worth further
exploration.
A previous study on intraocular cell populations of
two FUS cases reported a predominance of intraocular
CD8 + T cells with indications of clonogenic activation; in
these speciﬁc cases however the RV involvement was not
known.28 Our results revealed clear T-cell inﬁltration,
with a slight predominance of CD8 + T-cells above
CD4 + T-cells in one patient, but equal distribution
between CD4+ and CD8 + T-cells in the other. This indi-
cates that RVU may not necessarily be associated with a
predominance of CD8 + T-cells; possibly the stage of the
disease can play a role in the intraocular cellular
distribution.
In conclusion, our study shows that RVU patients
had a distinct intraocular cytokine proﬁle compared to
noninfectious uveitis entities and cataract and were
characterized by high levels of MCP-1 and IL-6rα,
low levels of PlGF, and intraocular inﬁltration with
CD8+ and CD4 + T-cells.
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